Yonatan Malca - 01 Jan 2022 Form 3 Insider Report for Entera Bio Ltd. (ENTX)

Role
Director
Signature
/s/ Dana Yaacov-Garbeli , Attorney-in-fact
Issuer symbol
ENTX
Transactions as of
01 Jan 2022
Net transactions value
$0
Form type
3
Filing time
14 Jan 2022, 06:03:40 UTC
Next filing
18 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ENTX Stock Option (right to buy) 01 Jan 2022 Ordinary Shares, par value NIS 0.0000769 per share 33,638 $3.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vested ratably on a quarterly basis over a three-year period that commenced on December 27, 2018.

Remarks:

See Exhibit 24.1 - Power of Attorney